Filed 9 Oct 2026
Last verified 14 Oct 2026Offering in progress. A listing date has not been announced, and proposed terms may change.
Company overview
Bambusa Therapeutics websiteBambusa Therapeutics is a clinical-stage biopharmaceutical company. It is developing long-acting precision bispecific antibodies for immunology and inflammation.
- Company country
- United States
Offering details
USD · Base offering, before overallotment
- Exchange
- Nasdaq Global Select Market
- Ticker
- BBTX